Title |
RraAS2 requires both scaffold domains of RNase ES for high-affinity binding and inhibitory action on the ribonucleolytic activity |
Author |
Jihune Heo1, Daeyoung Kim1, Minju Joo1, Boeun Lee1, Sojin Seo1, Jaejin Lee1, Saemee Song2, Ji-Hyun Yeom1, Nam-Chul Ha2, and Kangseok Lee1* |
Address |
1Department of Life Science, Chung-Ang University, Seoul 06974, Republic of Korea, 2Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea |
Bibliography |
Journal of Microbiology, 54(10),660-666, 2016,
|
DOI |
10.1007/s12275-016-6417-9
|
Key Words |
Streptomyces coelicolor, RNA stability, RNase
ES, RraAS2 |
Abstract |
RraA is a protein inhibitor of RNase E (Rne), which catalyzes
the endoribonucleolytic cleavage of a large proportion
of RNAs in Escherichia coli. The antibiotic‐producing bacterium
Streptomyces coelicolor also contains homologs of
RNase E and RraA, designated as RNase ES (Rns), RraAS1,
and RraAS2, respectively. Here, we report that RraAS2 requires
both scaffold domains of RNase ES for high-affinity
binding and inhibitory action on the ribonucleolytic activity.
Analyses of the steady-state level of RNase E substrates indicated
that coexpression of RraAS2 in E. coli cells overproducing
Rns effectively inhibits the ribonucleolytic activity of
full-length RNase ES, but its inhibitory effects were moderate
or undetectable on other truncated forms of Rns, in which the
N- or/and C-terminal scaffold domain was deleted. In addition,
RraAS2 more efficiently inhibited the in vitro ribonucleolytic
activity of RNase ES than that of a truncated form
containing the catalytic domain only. Coimmunoprecipitation
and in vivo cross-linking experiments further showed
necessity of both scaffold domains of RNase ES for high-affinity
binding of RraAS2 to the enzyme, resulting in decreased
RNA-binding capacity of RNase ES. Our results indicate that
RraAS2 is a protein inhibitor of RNase ES and provide clues
to how this inhibitor affects the ribonucleolytic activity of
RNase ES. |